Facilitators and barriers of lung cancer screening participation: umbrella and systematic review of the global evidence.

ABSTRACT:

Introduction

Lung cancer is the leading cancer worldwide, accounting for 2.5 million new cases and 1.8 million deaths in 2022. Early identification of lung cancer through low-dose computed tomography screening is associated with improved outcomes. However, in areas where lung cancer screening (LCS) is currently offered, participation is generally low. LCS is expanding worldwide and is a rapidly evolving field. This comprehensive review aimed to synthesise existing literature on factors associated with LCS participation.

Methods

PubMed, CINAHL, and PsycINFO were searched for peer-reviewed articles. Systematic reviews published before 2021 were reviewed and synthesised, while a top-up systematic review of original research published from 2021 onward was conducted. Data on faci

SUBMITTER: Belachew SA 

PROVIDER: S-EPMC12400730 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature